Cover Image

Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs

Abstract There is growing interest in the use of long‐acting (LA) injectable drugs to improve treatment adherence. However, their long elimination half‐life complicates the conduct of clinical trials. Physiologically‐based pharmacokinetic (PBPK) modeling is a mathematical tool that allows to simulat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sara Bettonte (Author), Mattia Berton (Author), Manuel Battegay (Author), Felix Stader (Author), Catia Marzolini (Author)
Format:	Book
Published:	Wiley, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Magnitude of Drug-Drug Interactions in Special Populations
by: Sara Bettonte, et al.
Published: (2022)

A Comprehensive Framework for Physiologically‐Based Pharmacokinetic Modeling in Matlab
by: Felix Stader, et al.
Published: (2019)

Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
by: A R Maharaj, et al.
Published: (2014)

Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
by: Abdul Naveed Shaik, et al.
Published: (2019)

Pharmacokinetics of antiretroviral drugs in infancy
by: Helen McIlleron, et al.
Published: (2009)

Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV
by: Paul Thoueille, et al.
Published: (2024)

Prescribing issues in older adults living with HIV: thinking beyond drug-drug interactions with antiretroviral drugs
by: Françoise Livio, et al.
Published: (2019)

Prediction of Drug-Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation
by: Deok Yong Yoon, et al.
Published: (2021)

A guide to developing population files for physiologically‐based pharmacokinetic modeling in the Simcyp Simulator
by: Liam Curry, et al.
Published: (2024)

First-in-human study to investigate the safety and pharmacokinetics of salvianolic acid A and pharmacokinetic simulation using a physiologically based pharmacokinetic model
by: Jinliang Chen, et al.
Published: (2022)

Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors
by: Weize Huang, et al.
Published: (2022)

Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics
by: Xinxin Yang, et al.
Published: (2023)

Physiologically Based Pharmacokinetic Modelling of Cabozantinib to Simulate Enterohepatic Recirculation, Drug-Drug Interaction with Rifampin and Liver Impairment
by: Bettina Gerner, et al.
Published: (2021)

Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation
by: Colleen Kuemmel, et al.
Published: (2020)

Building a Human Physiologically Based Pharmacokinetic Model for Aflatoxin B1 to Simulate Interactions with Drugs
by: Orphélie Lootens, et al.
Published: (2023)

Physiologically Based Pharmacokinetic Modelling and Simulation to Predict the Plasma Concentration Profile of Doxorubicin
by: George A. Mystridis, et al.
Published: (2022)

Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs
by: Helen Humphries, et al.
Published: (2021)

Prediction of Drug-Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation
by: Beihong Ji, et al.
Published: (2019)

Prediction of Pharmacokinetic Drug–Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic Modeling
by: Bu F, et al.
Published: (2024)

Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological‐based pharmacokinetic modeling
by: Karsten Menzel, et al.
Published: (2023)

Pharmacokinetic behavior of 16-dehydropregnenolone after intramuscular administration in rats
by: Hong-Ying Yang, et al.
Published: (2011)

Evaluating Drug Interactions between Ritonavir and Opioid Analgesics: Implications from Physiologically Based Pharmacokinetic Simulation
by: Liang Ni, et al.
Published: (2024)

Physiologically‐Based Pharmacokinetic Model‐Informed Drug Development for Fenebrutinib: Understanding Complex Drug‐Drug Interactions
by: Yuan Chen, et al.
Published: (2020)

Pharmacokinetics and Pharmacodynamics Modeling and Simulation Systems to Support the Development and Regulation of Liposomal Drugs
by: Hua He, et al.
Published: (2019)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
by: Xiaoxia eYang, et al.
Published: (2015)

Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats
by: Yoo-Kyung Song, et al.
Published: (2021)

Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions
by: Subrata Deb, et al.
Published: (2021)

Physiologically‐based pharmacokinetic model of sparsentan to evaluate drug-drug interaction potential
by: Nikunjkumar K. Patel, et al.
Published: (2024)

Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug-Drug Interactions of Phenytoin
by: Leyanis Rodriguez-Vera, et al.
Published: (2023)

Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development
by: Dion R. Brocks, et al.
Published: (2018)

Swine as the Animal Model for Testing New Formulations of Anti-Inflammatory Drugs: Carprofen Pharmacokinetics and Bioavailability of the Intramuscular Route
by: Lidia Gómez-Segura, et al.
Published: (2022)

Dose Prediction and Pharmacokinetic Simulation of XZP-5610, a Small Molecule for NASH Therapy, Using Allometric Scaling and Physiologically Based Pharmacokinetic Models
by: Lei Zhang, et al.
Published: (2024)

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
by: Venkata K. Yellepeddi, et al.
Published: (2021)

A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development
by: Trevor N. Johnson, et al.
Published: (2021)

Physiologic and Pharmacokinetic Changes in Pregnancy
by: Maged eCostantine
Published: (2014)

Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics
by: Zaril Zakaria, et al.
Published: (2018)

Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects
by: Xin Luo, et al.
Published: (2024)

Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug-drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine
by: Lien Thi Ngo, et al.
Published: (2022)

Physiologically-based pharmacokinetic simulations in pharmacotherapy: selection of the optimal administration route for exogenous melatonin
by: Adriana Savoca, et al.
Published: (2019)

Evaluation of drug-drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling
by: Tao Ji, et al.
Published: (2022)